Eagle Pharmaceuticals Inc (EGRX)
0.8999
-1.09
(-54.78%)
USD |
OTCM |
Oct 04, 16:00
Eagle Pharmaceuticals Shareholders Equity (Annual)
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2022 | 233.56M |
| December 31, 2021 | 176.45M |
| December 31, 2020 | 186.01M |
| December 31, 2019 | 179.17M |
| December 31, 2018 | 160.76M |
| December 31, 2017 | 179.14M |
| Date | Value |
|---|---|
| December 31, 2016 | 151.23M |
| December 31, 2015 | 90.34M |
| September 30, 2014 | 33.10M |
| September 30, 2013 | 2.054M |
| September 30, 2012 | -12.10M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
176.45M
Minimum
2021
233.56M
Maximum
2022
193.80M
Average
182.59M
Median
Shareholders Equity (Annual) Benchmarks
| Eli Lilly and Co | 10.77B |
| Verrica Pharmaceuticals Inc | 19.76M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |